Plasma Therapy Market Scope And Analysis

Report Code : TIPRE00004429
Category : Pharmaceuticals

No. of Pages : 150

Buy Now

Plasma Therapy Market Analysis Report 2021 to 2022

Buy Now

Plasma Therapy Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 390.25 Million
Market Size by 2030	US$ 1,097.64 Million
Global CAGR (2022 - 2030)	13.80%
Historical Data	2020-2022
Forecast period	2022-2030
Segments Covered	By Type Pure PRP Leukocyte-Rich PRP Pure Platelet-Rich Fibrin Leukocyte-Rich Fibrin By Source Autologous and Allogeneic By Application Orthopedic Conditions Dermatology Dental Issues By End User Hospitals and Clinics Research Institutes Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Biotest CSL Ltd Grifols Kedrion S p A China Biologics Inc Octapharma Cambrin Biologics LFB SA Biolife Plasma Services

Regional Analysis

North America dominated the plasma therapy market in 2022. It is further expected to record the highest CAGR in the market during 2022–2030. The market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share of the global plasma therapy market. Market growth in the country is attributed to the burgeoning adoption of platelet-rich plasma (PRP) in orthopedic and cosmetic surgeries, rising investments in the healthcare sector, dynamics research and development landscape, and USFDA approval for selected PRP therapies.

The report profiles leading players operating in the global plasma therapy market. These include BioLife Plasma Services; Takeda Pharmaceutical Company Limited; Biotest AG CSL Ltd.; Grifols, S.A.; Kedrion S.p.A; ImmunoTek Bio Centers; Bio Products Laboratory Ltd.; China Biologic Products Holdings, Inc.; Octapharma AG; and Origin, Inc. These leading players focus on expanding and diversifying their market presence and clientele, thereby tapping prevailing business opportunities.

Key Developments by Major Market Players are:

In March 2023, BioLife Plasma Services announced the opening of its plasma donation center in the US with new locations in West Springfield (Massachusetts) and Pearland (Texas). This expansion would help the company expand its business network.
In February 2021, Atlas Health Medical Group launched the SkinPen. This small pen-shaped microneedling device containing PRP for facelifts punctures the skin and stimulates an anti-aging response.
In March 2020, Takeda Pharmaceutical Company Limited initiated the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-Ig) to treat individuals suffering from severe COVID-19.